In this episode, Scott Becker emphasizes the importance of accountability and leadership over blaming external factors.

In this episode, Scott Becker examines Chipotle’s 50% YTD decline,

In this episode, reviews the YTD performance of Blackstone, KKR, and Apollo, & Carlyle Group.

In this episode, Scott Becker covers Rivian’s strong growth, Tesla’s steady progress, and Lucid’s challenges.

In this episode, Scott Becker shares five quick business updates, including a market surge following optimism over the government shutdown, Nvidia’s continued strong YTD performance, and more.

In this episode, Steven Ringel, CEO of the Kizuna Foundation and Nome Therapeutics, joins the podcast to discuss how his team is using artificial intelligence to make personalized medicine accessible for rare disease patients. 

In this episode, Scott Becker shares a lighthearted take on recovering from a day of indulgence,

In this episode, Scott Becker explores how well-intentioned government subsidies for college education and healthcare have unintentionally driven up costs, fueled historic debt, and created financial strain.

In this episode, Scott Becker breaks down how major health insurers are seeing significant stock declines as a government deal may alter affordable care subsidies.

In this episode, Scott Becker discusses Surgery Partners’ quarterly results.